Lorena de la Peña Selected Research

Lorena de la Peña Research Topics

6	Breast Neoplasms (Breast Cancer) 01/2019 - 04/2015
4	Neoplasms (Cancer) 01/2019 - 06/2006
3	Pathologic Complete Response 01/2019 - 04/2015
1	Heart Failure 01/2019
1	Infections 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Hypertensive Encephalopathy 01/2019
1	Mastodynia 01/2019
1	Glioma (Gliomas) 06/2006
1	Brain Neoplasms (Brain Tumor) 01/2006

3	Trastuzumab (Herceptin)FDA Link 02/2017 - 04/2015
3	Lapatinib (GW572016)FDA Link 02/2017 - 04/2015
2	Hormones (Hormone)IBA 01/2019 - 01/2017
2	Phenobarbital (Luminal)FDA Link 01/2019 - 01/2017
2	human ERBB2 proteinIBA 02/2017 - 04/2015
1	ribociclibIBA 01/2019
1	palbociclibIBA 01/2019
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2019
1	Letrozole (Femara)FDA LinkGeneric 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Epirubicin (Ellence)FDA LinkGeneric 02/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017
1	Fluorouracil (Carac)FDA LinkGeneric 02/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2015
1	ErbB Receptors (EGF Receptor)IBA 04/2015
1	perifosineIBA 06/2006
1	RNA (Ribonucleic Acid)IBA 01/2006